The study demonstrates a successful post-embedding immunogold labeling procedure for localizing HTLV-I gag proteins p19 and p24 on virions.
Answers are grounded in this paper and cite their sources.
May aid preclinical HTLV-I virion studies; leaves open human applicability and clinical translation.
We developed a post-embedding immunogold labeling procedure for the ultrastructural localization of the HTLV-I gag proteins p19 and p24 by the use of monoclonal antibodies (MAb). Both antigens were shown to withstand fixation with 1% glutaraldehyde. In addition, p19 antigenicity was found not to be affected by post-fixation with 1% osmium tetroxide. The choice of resin played a decisive role in the retention of antigenicity. P19 was preserved in Lowicryl K4M as well as in LR White, whereas p24 was preserved only in Lowicryl. Both p19 and p24 were found to be localized on the HTLV-I virions themselves, whereas no positive immunostaining could be observed on the infected cells. In Lowicryl-embedded samples, in which both antigens had been preserved, a double immunogold labeling procedure was performed that allowed the co-localization of p19 and p24 on the same section. In osmicated LR White-embedded samples the quality of ultrastructural preservation of HTLV-I virions was found to be comparable to results obtained with the traditional glutaraldehyde-osmium tetroxide-epoxy resin processing.
No takes yet. Share an insight, caveat, or question.
Stransky et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: